Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07467525

Neuromuscular Effects of Acute Fatigue in Adolescent Basketball

Effects of Acute Fatigue on Neuromuscular Control and Performance Parameters in Professional Adolescent Basketball Players: A Sex-Based Subgroup Analysis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Biruni University · Academic / Other
Sex
All
Age
13 Years – 18 Years
Healthy volunteers
Accepted

Summary

The primary aim of this study is to investigate the effects of acute fatigue on neuromuscular control and performance parameters in professional adolescent basketball players and to determine the relationship between fatigue level and neuromuscular control variables. As a secondary aim, the study seeks to examine whether these effects differ according to sex. The research hypotheses are as follows. The null hypothesis (H1-0) states that acute fatigue has no significant effect on neuromuscular control parameters in adolescent basketball players, including balance performance, landing mechanics, ground contact time, and asymmetry ratios. The alternative hypothesis (H1-1) proposes that acute fatigue has a significant effect on these neuromuscular control parameters. The second null hypothesis (H2-0) states that the effects of acute fatigue on neuromuscular control parameters do not differ according to sex. The alternative hypothesis (H2-1) suggests that the effects of acute fatigue on neuromuscular control parameters differ according to sex.

Conditions

Interventions

TypeNameDescription
OTHERbasketball practiceThe athletes' training session will consist of a 30-minute general and sport-specific warm-up period followed by a 90-minute basketball-specific ball training session. These training sessions will be conducted in accordance with the club's standard training program and will include technical and tactical drills, game-based exercises, movements involving changes of direction, jump-landing activities, and short-duration sprint efforts.

Timeline

Start date
2026-03-16
Primary completion
2026-03-20
Completion
2026-04-15
First posted
2026-03-12
Last updated
2026-03-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07467525. Inclusion in this directory is not an endorsement.